You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 4, April 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (61)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Anticoagulants, Venous Thromboembolism, and the Cancer Patient

Francis D. Moore, Jr, MD; Robert T. Osteen, MD; Daniel D. Karp, MD; Glenn Steele, Jr, MD; Richard E. Wilson, MD

Arch Surg. 1981;116(4):405-407.


Abstract

• The records of 32 cancer patients who were treated with heparin sodium and warfarin sodium for thromboembolic disease were reviewed. Standard techniques for anticoagulation were neither safe nor effective. Sixteen patients experienced 21 different hemorrhagic complications. Eight patients had major hemorrhages that led to cessation of therapy or death. Six of 32 patients had pulmonary embolisms while receiving anticoagulants. It is suggested that venous interruption may be a safer and more effective method of prophylaxis against pulmonary embolism in cancer patients.

(Arch Surg 1981;116:405-407)



Author Affiliations

From the Department of Surgery (Drs Moore, Osteen, Steele, and Wilson), Peter Bent Brigham Hospital; and the Department of Medicine (Dr Karp), Sidney Farber Cancer Institute, Harvard Medical School, Boston.


Footnotes

Accepted for publication Nov 19, 1980.

Reprint requests to Peter Bent Brigham Hospital, 721 Huntington Ave, Boston, MA 02115 (Dr Osteen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vena Caval Filters: A Review for Intensive Care Specialists
Streiff
J Intensive Care Med 2003;18:59-79.
ABSTRACT  

Incidence of Recurrent Thromboembolic and Bleeding Complications Among Patients With Venous Thromboembolism in Relation to Both Malignancy and Achieved International Normalized Ratio: A Retrospective Analysis
Hutten et al.
JCO 2000;18:3078-3083.
ABSTRACT | FULL TEXT  

Cancer, Coagulation, and Anticoagulation
Letai and Kuter
The Oncologist 1999;4:443-449.
ABSTRACT | FULL TEXT  

A Free-Floating Thrombus in the Inferior Vena Cava Associated with Lung Cancer: Complete Thrombectomy Using a Simple Clamping Procedure A Case Report
Kawashima et al.
VASC ENDOVASCULAR SURG 1998;32:391-395.
ABSTRACT  

Experimental Evaluation of a Retrievable Vena Cava Filter
Nakagawa et al.
VASC ENDOVASCULAR SURG 1994;28:7-14.
ABSTRACT  

Physician Practices in the Treatment of Pulmonary Embolism and Deep Venous Thrombosis
Wheeler et al.
Arch Intern Med 1988;148:1321-1325.
ABSTRACT  

Disseminated Intravascular Coagulation and the Mobin-Uddin Vena Cava Umbrella Filter in a Patient with a Hypercoagulable State
Mizock and Shah
VASC ENDOVASCULAR SURG 1985;19:122-125.
ABSTRACT  

Management of Oral Anticoagulant Therapy: Experience With an Anticoagulation Clinic
Errichetti et al.
Arch Intern Med 1984;144:1966-1968.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.